AMGEN ANNOUNCES 2026 FOURTH QUARTER DIVIDEND

What happened

Amgen's board declared a $2.52 per share dividend for the fourth quarter of 2026, payable on December 11, 2026, to stockholders of record at the close of business on November 20, 2026.

Confirmed

Global impact / market context

A dividend is cash paid to shareholders, so the board is committing company cash to owners rather than keeping it for research, manufacturing or debt. The fixed $2.52 amount signals confidence in cash generation and gives income-focused investors a known payout date.

Analyst inference

Amgen is a large biotechnology company in the Dow Jones Industrial Average and Nasdaq-100, so its payout decision draws attention from income and index investors. A steady quarterly dividend can support shareholder returns, but the cash paid out is money not available for pipeline spending or buybacks.

Analyst inference

What to watch

1. Watch the November 20, 2026 record date, which means the cut-off for stockholders to be listed and receive the dividend, and the December 11, 2026 payment date. Confirmed
2. Watch whether Amgen's board keeps declaring similar quarterly dividends in later periods, since each payout is a separate board decision and this announcement covers only the 2026 fourth quarter. Proposed
3. Watch Amgen's cash flow and research spending, because paying $2.52 per share reduces cash available for its drug pipeline, manufacturing and debt needs, which could shape future dividend decisions. Analyst inference

Evidence

• Original source link unavailable